Cardiogenics Holdings Stock Filter Stocks by Fundamentals
| CGNH Stock | USD 0.0001 0.00 0.00% |
CardioGenics Holdings fundamentals help investors to digest information that contributes to CardioGenics Holdings' financial success or failures. It also enables traders to predict the movement of CardioGenics Pink Sheet. The fundamental analysis module provides a way to measure CardioGenics Holdings' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CardioGenics Holdings pink sheet.
CardioGenics |
Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
| All Next | Launch Module |
CardioGenics Fundamentals
| Return On Asset | -1.15 | |||
| Current Valuation | 2.3 M | |||
| Shares Outstanding | 96.05 M | |||
| Shares Owned By Insiders | 2.52 % | |||
| Price To Earning | (0.67) X | |||
| Price To Sales | 80,069 X | |||
| EBITDA | (753.55 K) | |||
| Net Income | (1.92 M) | |||
| Cash And Equivalents | 96.81 K | |||
| Current Ratio | 0.16 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (606.64 K) | |||
| Earnings Per Share | (0.01) X | |||
| Target Price | 2.0 | |||
| Beta | 97.17 | |||
| Market Capitalization | 1.92 M | |||
| Total Asset | 231.93 K | |||
| Retained Earnings | (49.68 M) | |||
| Working Capital | (1.96 M) | |||
| Current Asset | 385 K | |||
| Current Liabilities | 2.35 M | |||
| Net Asset | 231.93 K |
About CardioGenics Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CardioGenics Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CardioGenics Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CardioGenics Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in CardioGenics Pink Sheet
CardioGenics Holdings financial ratios help investors to determine whether CardioGenics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CardioGenics with respect to the benefits of owning CardioGenics Holdings security.